Special Issues

Faculty Perspectives

MOA Magnifier: The Important Role of YERVOY® (ipilimumab) in Combination with OPDIVO® (nivolumab)		View this Issue
Faculty Perspectives: Clinical Relevance and Rationale of Using MSI-H/dMMR Biomarkers in Immunotherapy of Colorectal Cancer and Other Solid Tumors \| Part 3 of a 4-Part Series		View this Issue
Faculty Perspectives: Rationale for PD-L1 Expression as a Biomarker in Immuno-Oncology \| Part 2 of a 4-Part Series		View this Issue
Faculty Perspectives: An Overview of Existing and Emerging Biomarkers in Oncology \| Part 1 of a 4-Part Series		View this Issue
Faculty Perspectives in Chronic Pain Utilizing Pharmacogenomics When Selecting Personalized Medicine for Patients with Chronic Pain	Part 5 A of 5	View this Issue
Faculty Perspectives in Chronic Pain Epidemiologic Assessments of Abuse-Deterrent Formulations	Part 4 of 5	View this Issue
Faculty Perspectives in Chronic Pain In Vitro and Clinical Assessments of Abuse-Deterrent Formulations for Chronic Pain	Part 3 of 5	View this Issue
Faculty Perspectives in Chronic Pain Solutions to Public Health Issues in Chronic Pain	Part 2 of 5	View this Issue
Faculty Perspectives in Chronic Pain Socioeconomic Burden of Chronic Pain	Part 1 of 5	View this Issue
September 2014 A Focus on Polycythemia Vera and Myelofibrosis: Updates from ASCO and EHA 2014	Vol 4 No 1	View this Issue
June 2013 Novel Approaches in the Treatment of Hematologic Malignancies Utilizing Bendamustine	Vol 4 No 4	View this Issue
May 2013 Safety of Bendamustine in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma	Vol 4 No 3	View this Issue
March 2013 Efficacy of Bendamustine in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma	Vol 4 No 2	View this Issue
December 2012 A Retrospective Review of the Characterization of Bendamustine	Vol 4 No 1	View this Issue

Conquering the Cancer Care Continuum

Fifth Issue Pediatric Cancer Care	Series Three	View this Issue
Fourth Issue Impact of the Affordable Care Act on Cancer Care	Series Three	View this Issue
Third Issue Advances in Side Effect Management	Series Three	View this Issue
Second Issue Access to Care	Series Three	View this Issue
First Issue Good Manufacturing Process	Series Three	View this Issue
Sixth Issue Biosimilars in Oncology	Series Two	View this Issue
Fifth Issue Cancer Survivorship Care Plans	Series Two	View this Issue
Fourth Issue Personalized Treatment Planning	Series Two	View this Issue
Third Issue Hospice Care	Series Two	View this Issue
Second Issue Pain Management in Oncology	Series Two	View this Issue
First Issue Palliation in Cancer Care	Series Two	View this Issue

Ask the Expert

Ask the Expert: First-Line Treatment of Metastatic Non-small cell Lung Cancer (NSCLC)

View this Issue